INTRODUCTION
============

Menopause is often characterized by many changes that may induce a phase of rapid decreases in bone mineral density, aerobic fitness, muscle strength, and balance, especially in sedentary women ([@b1-jer-10-2-89-7]). Follicle-stimulating hormone (FSH) is a glycoprotein gonadotropin secreted by the anterior pituitary in response to gonadotropin-releasing hormone (GnRH), which is released by the hypothalamus. FSH directly plays an important role in regulation of bone mass directly by stimulating osteoclastic bone resorption ([@b7-jer-10-2-89-7]). [@b2-jer-10-2-89-7] reported that bone mineral density significantly decreased in relation to increased FSH levels in postmenopausal women. Bone remodeling involves bone resorption and bone formation. Bone formation was assessed by serum osteocalcin (OC), serum bone-specific alkaline phosphatase (B-ALP), serum C-propeptide of type I collagen (PICP), and bone resorption by C-telopeptide (CTx) and N-terminal telopeptide (NTX). Of these, NTx is a direct degradation product of the bone resorption process conducted by osteoclasts and elevated levels of NTx indicate increased bone resorption ([@b8-jer-10-2-89-7]).

Cardio Tennis is new sports tennis type exercise that combines the best features of the sport of tennis with cardiovascular exercise. However, the effects of new sports tennis type exercise on aerobic capacity, FSH, and NTX have not yet been explored. In the present study, we investigated the effects of new sports tennis type exercise on aerobic capacity, FSH and NTX in the postmenopausal women.

MATERIALS AND METHODS
=====================

Subjects
--------

Subjects were consisted of 20 postmenopausal women, who had not menstruated for at least 1 yr and had follicle-stimulating hormone levels \>35 mIU/L, estradiol levels\<40 pg/mL. The subjects were randomly divided into two groups: control group (n=10), new sports tennis type exercise group (n=10). The physical characteristics of subjects are shown in [Table 1](#t1-jer-10-2-89-7){ref-type="table"}.

Aerobic capacity
----------------

In order to estimate VO~2~max, ventilation (VE), before and after the training intervention, each performed a graded exercise test on a treadmill using the Bruce's protocol.

Exercise training protocol
--------------------------

New sports tennis type exercise was consisted of warm up (10 min), main exercise (40 min), cool down (10 min) 3 days a per weeks for 12 weeks. New sports tennis type exercise program comprises circuit exercise including side step, cross over step, sprint & back step, running, forehand stroke drill, back-hand stroke drill, forehand and back hand running stroke drill, and approach drill. Training intensity was consisted of 50 to 60% HR-max at 1--6 weeks and 61--70% HRmax at 7--12 weeks using Karvonen's equation.

Blood sampling and analysis
---------------------------

Blood sampling was performed before the exercise, after 6 weeks, and after 12 weeks. All samples were placed in 300 μL aliquots in Eppendorf^®^ tubes, stored at −70°C. FSH was as analyzed by radioimmunoassay (ADVIA Centaur^®^, Bayer Health care, Tarrytown, NY, USA). NTx was measured by enzyme linked immunoassay (Ostex International Inc., Seattle, WA, USA).

Data analysis
-------------

The results were analyzed by two-way repeated measures ANOVA and Duncan's post-hoc test was performed. Statistical significance was set at *P*\<0.05.

RESULTS
=======

Changes of 12 weeks new sports tennis type exercise on aerobic capacity
-----------------------------------------------------------------------

The results are presented in [Table 2](#t2-jer-10-2-89-7){ref-type="table"}. VO2max and ventilation were significantly increased after 6 weeks and 12 weeks (*P*= 0.008, *P*=0.017, respectively). The VO~2~max and ventilation were higher in the exercise group than those in the control group after 6 weeks and 12 weeks. However, interaction between group and time showed no significant difference.

Changes of 12 weeks new sports tennis type exercise on FSH and NTx
------------------------------------------------------------------

The results are presented in [Table 3](#t3-jer-10-2-89-7){ref-type="table"}. FSH was significantly decreased after 12 weeks (*P*=0.04). FSH was lower in the exercise group than those in the control group after 12 weeks. However, interaction between group and time showed no significant difference. NTx was lower in the exercise group than those in the control group (*P*=0.009). However, interaction between group and time showed no significant difference.

DISCUSSION
==========

Exercise is generally considered providing an osteogenic stimulus to the bones, by increasing serum concentrations of bone formation markers as well as decreasing bone reabsorption markers ([@b3-jer-10-2-89-7]). In the present study, we investigated about effects of 12 weeks of new sports tennis type exercise on aerobic capacity, FSH and NTx in the postmenopausal women.

Aerobic exercise training is known to improve aerobic capacity in postmenopausal women ([@b5-jer-10-2-89-7]). In the present study, 12 weeks of new sports tennis type exercise training, VO2max and VE levels were increased in new sports tennis type exercise group compared with the control group.

Serum FSH is a marker of bone loss ([@b7-jer-10-2-89-7]). [@b7-jer-10-2-89-7] reported that enhanced FSH levels may directly induce bone loss. In the present study, new sports tennis type exercise significantly increased FSH levels, indicating biochemical markers of bone reabsorption.

NTX is established biochemical markers of bone formation and reabsorption, respectively, and may be used as reliable measures of bone metabolism ([@b4-jer-10-2-89-7]). [@b9-jer-10-2-89-7] reported that walking exercises decreased urine NTx levels in post-menopausal osteopenic women after the 12 months exercise training. However, [@b6-jer-10-2-89-7] demonstrated that walking and high-impact exercises did not change NTx levels significantly. In the present study, NTx levels showed a decrease in the NTx levels by 12 weeks of new sports tennis type exercise, but had no significant difference. These findings indicate that 12 weeks of new sports tennis type exercise can be effective in prevention of bone loss and aerobic capacity impairment in postmenopausal women.
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###### 

Physical characteristics of subjects

  Groups       Age (yr)      Weight (kg)   Height (cm)    BMI (kg/m^2^)
  ------------ ------------- ------------- -------------- ---------------
  EG (n= 10)   55.13± 3.24   62.22± 3.76   158.29± 3.41   24.92± 1.12
  CG (n= 10)   54.11± 1.78   61.31± 2.64   157.34± 4.51   24.87± 1.53

Values are mean± SD. EG, exercise group; CG, control group.

###### 

Change of aerobic capacity

  Item                   Groups        O week           6 weeks          12 weeks                                                    2-way ANOVA   F                                                         *P*
  ---------------------- ------------- ---------------- ---------------- ----------------------------------------------------------- ------------- --------------------------------------------------------- -----------------------------------------------------------
  VO~2~max (mL/kg/min)   EG            25.85± 2.62^a^   30.46± 3.75^b^   31.41± 5.21^c^                                              Group         29.901                                                    0.000[^\*\*\*^](#tfn5-jer-10-2-89-7){ref-type="table-fn"}
  CG                     23.77± 2.14   24.59± 1.04      24.86± 1.95      Time                                                        5.331         0.008[^\*\*^](#tfn4-jer-10-2-89-7){ref-type="table-fn"}   
                                                                         Group[^\*^](#tfn3-jer-10-2-89-7){ref-type="table-fn"}Time   2.482         0.094                                                     
  VE (l/min)             EG            47.17± 4.52^a^   55.98± 9.99^b^   57.76± 5.98^c^                                              Group         19.097                                                    0.000[^\*\*\*^](#tfn5-jer-10-2-89-7){ref-type="table-fn"}
  CG                     42.53± 7.44   44.95± 6.81      46.33± 9.37      Time                                                        4.464         0.017[^\*^](#tfn3-jer-10-2-89-7){ref-type="table-fn"}     
                                                                         Group[^\*^](#tfn3-jer-10-2-89-7){ref-type="table-fn"}Time   1.134         0.330                                                     

Different letters (a--c) denote statistically significant differences (*P*\< 0.05) after Duncan post-hoc. Values are mean± SD.

*P*\< 0.05.

*P*\< 0.01.

*P*\< 0.001. EG, exercise group; CG, control group.

###### 

Change of FSH and NTx

  Item           Groups        O week           6 weeks          12 weeks                                                    2-way ANOVA   F                                                       *P*
  -------------- ------------- ---------------- ---------------- ----------------------------------------------------------- ------------- ------------------------------------------------------- ---------------------------------------------------------
  FSH (mIU/mL)   EG            80.54± 9.83^a^   75.32± 7.05^a^   66.04± 16.55^b^                                             Group         5.457                                                   0.023[^\*^](#tfn7-jer-10-2-89-7){ref-type="table-fn"}
  CG             82.50± 8.45   76.74± 6.76      80.76± 7.91      Time                                                        3.431         0.040[^\*^](#tfn7-jer-10-2-89-7){ref-type="table-fn"}   
                                                                 Group[^\*^](#tfn7-jer-10-2-89-7){ref-type="table-fn"}Time   2.832         0.068                                                   
  NTx (nM BCE)   EG            17.2± 5.43       16.24± 4.25      15.30± 3.29                                                 Group         7.271                                                   0.009[^\*\*^](#tfn8-jer-10-2-89-7){ref-type="table-fn"}
  CG             17.0± 2.85    20.76± 2.33      19.02± 4.11      Time                                                        0.846         0.435                                                   
                                                                 Group[^\*^](#tfn7-jer-10-2-89-7){ref-type="table-fn"}Time   2.153         0.126                                                   

Different letters (a--b) denote statistically significant differences (*P*\< 0.05) after Duncan post-hoc. Values are mean± SD.

*P*\< 0.05.

*P*\< 0.01. EG, exercise group; CG, control group; FSH, follicular stimulating hormone; NTx, N-telopeptide.
